BMX-001: New Therapy Showing Increased Survival in Newly Diagnosed Glioblastoma
Time: 12:15 pm
day: Conference Day One
Details:
- New drug class – redox-active metallaporphyrins – positioned to transform the efficacy of radiation and chemotherapy in oncology
- Novel BMX-001 dual action enhances tumor killing while mitigating radiation-induced side-effects
- Discussion of ongoing randomized, 160 patient, multi-center trial
